Tehran University of Medical Sciences
Iranian Journal of Psychiatry
1735-4587
6
1
2011
03
15
The Factor Structure of the Revised Cheek and Buss Shyness Scale in an Undergraduate University Sample
19
24
Shahrum
Vahedi
Department of Educational Psychology, Faculty of Education and Psychology, University of Tabriz, Tabriz, Iran
2015
10
14
Objective: The present study examined the psychometric properties of the Persian version of the Revised Cheek and Buss Shyness Scale (RCBS) using confirmatory factor analysis among (n = 300) college students.
Method: A total of 300 undergraduate students participated in this study And completed the Revised Cheek and Buss Shyness Scale (RCBS). A confirmatory factor analysis was performed to test diagnosis as a unitary construct and to test an earlier-reported two-factor model.
Results: Results indicated that unidimensional measurement model of the RCBS did not provide the best fit for the data. Then three measurement models were tested, and the results showed that a two-factor model taking into account differences in the direction of item wording provided a satisfactory and parsimonious fit to the data. Multi-group confirmatory factor analysis was used to better understand the factorial invariance of the scale across genders, and indicated that two-factor structure of the RCBS was equivalent across genders. Supplementary t-tests revealed no other gender differences on shyness.
Conclusions: The results provide initial support for the construct validity of the self- report version of the RCBS in college students.
https://ijps.tums.ac.ir/index.php/ijps/article/view/334
https://ijps.tums.ac.ir/index.php/ijps/article/download/334/330
and after the drug substitution was assessed using a sexual questionnaire designed to assess four stages of sexual function.
Results: Compared to those who changed their medication to Haloperidol, the patients who remained on Risperidone therapy suffered from more sexual dysfunction, especially in their tendency towards having sexual activities (P= 0.01), post menstrual sexual activity (P= 0.002), and reaching orgasm in their sexual activities (P= 0.04); however in the Haloperidol group, no significant difference was observed before and after the change in medication.
Conclusion: Although Risperidone and Haloperidol can both disturb patients'sexual function, the side effects of Risperidone are stronger. Hence toprevent the decline of medication acceptance or irregular consumption by patients which may lead to possible relapse, substitution of Risperidone withanother drug with fewer side effects on sexual activities is definitely to the advantage of the patients .
https://ijps.tums.ac.ir/index.php/ijps/article/view/504
https://ijps.tums.ac.ir/index.php/ijps/article/download/504/466